Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,457 | 35,846 | 51,238 | 42,164 | 32,910 |
| Receivables | 138,406 | 120,525 | 128,303 | 130,404 | 132,367 |
| Inventories | 79,807 | 83,187 | 82,236 | 96,273 | 96,465 |
| TOTAL | $257,527 | $249,813 | $272,842 | $280,901 | $275,203 |
| Non-Current Assets | |||||
| PPE Net | 20,527 | 21,294 | 21,899 | 22,983 | 24,512 |
| Investments And Advances | 3,507 | 2,102 | 2,293 | 2,274 | 1,687 |
| Intangibles | 358,508 | 367,121 | 375,881 | 384,860 | 394,416 |
| Other Non-Current Assets | 33,277 | 10,209 | 10,644 | 10,575 | 10,970 |
| TOTAL | $415,819 | $400,726 | $410,717 | $420,692 | $431,585 |
| Total Assets | $673,346 | $650,539 | $683,559 | $701,593 | $706,788 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,750 | 18,750 | 15,000 | 11,250 | 43,358 |
| Accounts payable and accrued liabilities | 20,196 | 24,050 | 10,928 | 26,649 | 24,245 |
| Accrued Expenses | 109,361 | 101,135 | 130,242 | 119,446 | 113,666 |
| Other current liabilities | 4,144 | 4,160 | 4,210 | 4,407 | 4,411 |
| TOTAL | $152,451 | $148,095 | $160,380 | $161,752 | $185,680 |
| Non-Current Liabilities | |||||
| Long Term Debt | 229,702 | 253,326 | 278,951 | 311,334 | 297,880 |
| Other Non-Current Liabilities | 10,449 | 13,452 | 12,785 | 19,615 | 19,465 |
| TOTAL | $243,483 | $268,179 | $294,732 | $332,586 | $319,809 |
| Total Liabilities | $395,934 | $416,274 | $455,112 | $494,338 | $505,489 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,092 | 83,535 | 83,155 | 82,763 | 82,679 |
| Common Shares | 84 | 84 | 83 | 83 | 83 |
| Retained earnings | -298,375 | -331,816 | -334,929 | -349,684 | -352,839 |
| Other shareholders' equity | 47,778 | 43,085 | 42,442 | 39,322 | 39,283 |
| TOTAL | $277,412 | $234,265 | $228,447 | $207,255 | $201,299 |
| Total Liabilities And Equity | $673,346 | $650,539 | $683,559 | $701,593 | $706,788 |